These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 27509046)

  • 1. Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.
    Schabath MB; Massion PP; Thompson ZJ; Eschrich SA; Balagurunathan Y; Goldof D; Aberle DR; Gillies RJ
    PLoS One; 2016; 11(8):e0159880. PubMed ID: 27509046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
    Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
    Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers.
    Horeweg N; Scholten ET; de Jong PA; van der Aalst CM; Weenink C; Lammers JW; Nackaerts K; Vliegenthart R; ten Haaf K; Yousaf-Khan UA; Heuvelmans MA; Thunnissen E; Oudkerk M; Mali W; de Koning HJ
    Lancet Oncol; 2014 Nov; 15(12):1342-50. PubMed ID: 25282284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.
    Gierada DS; Pinsky P; Nath H; Chiles C; Duan F; Aberle DR
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25326638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival Following Detection of Stage I Lung Cancer by Screening in the National Lung Screening Trial.
    Gierada DS; Pinsky PF
    Chest; 2021 Feb; 159(2):862-869. PubMed ID: 32822676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening.
    Thomas A; Pattanayak P; Szabo E; Pinsky P
    Chest; 2018 Dec; 154(6):1284-1290. PubMed ID: 30080997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer.
    Field JK; Duffy SW; Baldwin DR; Brain KE; Devaraj A; Eisen T; Green BA; Holemans JA; Kavanagh T; Kerr KM; Ledson M; Lifford KJ; McRonald FE; Nair A; Page RD; Parmar MK; Rintoul RC; Screaton N; Wald NJ; Weller D; Whynes DK; Williamson PR; Yadegarfar G; Hansell DM
    Health Technol Assess; 2016 May; 20(40):1-146. PubMed ID: 27224642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How Are Indeterminate Pulmonary Nodules at Diagnosis Associated with Survival in Patients with High-Grade Osteosarcoma?
    Tsoi KM; Lowe M; Tsuda Y; Lex JR; Fujiwara T; Almeer G; Gregory J; Stevenson J; Evans SE; Botchu R; Jeys LM
    Clin Orthop Relat Res; 2021 Feb; 479(2):298-308. PubMed ID: 32956141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
    Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
    Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal multistage model for lung cancer incidence, mortality, and CT detected indolent and aggressive cancers.
    Hazelton WD; Goodman G; Rom WN; Tockman M; Thornquist M; Moolgavkar S; Weissfeld JL; Feng Z
    Math Biosci; 2012 Nov; 240(1):20-34. PubMed ID: 22705252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
    Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
    Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison Between Radiological Semantic Features and Lung-RADS in Predicting Malignancy of Screen-Detected Lung Nodules in the National Lung Screening Trial.
    Li Q; Balagurunathan Y; Liu Y; Qi J; Schabath MB; Ye Z; Gillies RJ
    Clin Lung Cancer; 2018 Mar; 19(2):148-156.e3. PubMed ID: 29137847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers.
    Diederich S; Thomas M; Semik M; Lenzen H; Roos N; Weber A; Heindel W; Wormanns D
    Eur Radiol; 2004 Apr; 14(4):691-702. PubMed ID: 14727146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HUNCHEST-II contributes to a shift to earlier-stage lung cancer detection: final results of a nationwide screening program.
    Kerpel-Fronius A; Megyesfalvi Z; Markóczy Z; Solymosi D; Csányi P; Tisza J; Kecskés A; Baranyi B; Csánky E; Dóka A; Gálffy G; Göcző K; Győry C; Horváth Z; Juhász T; Kállai Á; Kincses ZT; Király Z; Király-Incze E; Kostyál L; Kovács A; Kovács A; Kuczkó É; Makra Z; Maurovich Horvát P; Merth G; Moldoványi I; Müller V; Pápai-Székely Z; Papp D; Polgár C; Rózsa P; Sárosi V; Szalai Z; Székely A; Szuhács M; Tárnoki D; Tavaszi G; Turóczi-Kirizs R; Tóth L; Urbán L; Vaskó A; Vigh É; Dome B; Bogos K
    Eur Radiol; 2024 May; 34(5):3462-3470. PubMed ID: 37921926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of growth patterns of screen-detected lung cancers: The NELSON study.
    Heuvelmans MA; Vliegenthart R; de Koning HJ; Groen HJM; van Putten MJAM; Yousaf-Khan U; Weenink C; Nackaerts K; de Jong PA; Oudkerk M
    Lung Cancer; 2017 Jun; 108():48-54. PubMed ID: 28625647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term cancer risk associated with lung nodules observed on low-dose screening CT scans.
    Pinsky P; Gierada DS
    Lung Cancer; 2020 Jan; 139():179-184. PubMed ID: 31812129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Analysis of Clinical Characteristics and Prognosis Between Primary Lung Cancers Identified as Screening Detected and Incidentally Detected Pulmonary Nodules.
    Zo S; Kim C; Lee HY; Park G; Shin SH; Jeong BH; Lee K; Kim H; Kim HK; Um SW
    Anticancer Res; 2024 Jul; 44(7):3163-3173. PubMed ID: 38925826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of low-dose computed tomography (LDCT) screening for early lung cancer: prevalence in 4 690 asymptomatic participants].
    Tang W; Wu N; Huang Y; Wang J; Zhao S; Xu Z; Zhang K; Jiang Y; Cai Q; Zhou L; Li M; Tao D; Liu X; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Jul; 36(7):549-54. PubMed ID: 25327664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.
    Hocking WG; Hu P; Oken MM; Winslow SD; Kvale PA; Prorok PC; Ragard LR; Commins J; Lynch DA; Andriole GL; Buys SS; Fouad MN; Fuhrman CR; Isaacs C; Yokochi LA; Riley TL; Pinsky PF; Gohagan JK; Berg CD;
    J Natl Cancer Inst; 2010 May; 102(10):722-31. PubMed ID: 20442215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.